HYLENEX Recombinant
Hyaluronidase
- Strength
- 150 [USP'U]/mL
- Form
- Injection, Solution
- Class
- Endoglycosidase
Antares Pharma, Inc.
Not stocked by us — reference only
Listed by HF Acquisition Co LLC, DBA HealthFirst
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Endoglycosidase |
| Approval route | BLA — biologic licence |
| NDC code | 51662-1555 |
| FDA application | BLA021859 |
| RxNorm concept | 630936 |
| Package sizes listed | 1 |
| Marketed since | June 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hyaluronidase
Antares Pharma, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.